Patients with osteoporosis on steroid medication tend to sustain subsequent fractures

Akio Hiwatashi, P. L. Westesson

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

BACKGROUND AND PURPOSE: Repeat fractures after percutaneous vertebroplasty can be seen in patients with osteoporotic compression fractures. The purpose of this study was to identify characteristics of patients with new fractures after vertebroplasty. MATERIALS AND METHODS: Fifty-five consecutive patients were treated with vertebroplasty for painful osteoporotic compression fractures at our institution. The charts and radiographic studies of all patients were retrospectively reviewed. Special attention was paid to patient age and sex, imaging studies, long-term use of steroid medication, and treatment for osteoporosis. We used logistic regression analysis and the Fisher exact test for statistical evaluation. RESULTS: Thirty-five patients were treated with vertebroplasty at one time and did not develop new fractures, whereas 20 patients returned with new fractures. Sixteen of 55 patients had been on steroid medication. The incidence of subsequent vertebral compression fractures after vertebroplasty in patients on long-term steroid therapy was 69% (11/16), compared with 23% (9/39) in those with primary osteoporosis (ie, those who were not on steroid therapy). There was a statistically significant association between use of steroids and new fractures (P < .01). No statistically significant difference was noted in patient age, sex, and medication for osteoporosis. CONCLUSION: Patients who are on long-term steroid medication have an elevated risk of developing new fractures after vertebroplasty.

Original languageEnglish
Pages (from-to)1055-1057
Number of pages3
JournalAmerican Journal of Neuroradiology
Volume28
Issue number6
DOIs
Publication statusPublished - Jun 1 2007

Fingerprint

Osteoporosis
Steroids
Vertebroplasty
Compression Fractures
Osteoporotic Fractures
Therapeutics
Logistic Models
Regression Analysis
Incidence

All Science Journal Classification (ASJC) codes

  • Radiology Nuclear Medicine and imaging
  • Clinical Neurology

Cite this

Patients with osteoporosis on steroid medication tend to sustain subsequent fractures. / Hiwatashi, Akio; Westesson, P. L.

In: American Journal of Neuroradiology, Vol. 28, No. 6, 01.06.2007, p. 1055-1057.

Research output: Contribution to journalArticle

@article{2a448dc26a3e4e8aa3aa08f1757ae071,
title = "Patients with osteoporosis on steroid medication tend to sustain subsequent fractures",
abstract = "BACKGROUND AND PURPOSE: Repeat fractures after percutaneous vertebroplasty can be seen in patients with osteoporotic compression fractures. The purpose of this study was to identify characteristics of patients with new fractures after vertebroplasty. MATERIALS AND METHODS: Fifty-five consecutive patients were treated with vertebroplasty for painful osteoporotic compression fractures at our institution. The charts and radiographic studies of all patients were retrospectively reviewed. Special attention was paid to patient age and sex, imaging studies, long-term use of steroid medication, and treatment for osteoporosis. We used logistic regression analysis and the Fisher exact test for statistical evaluation. RESULTS: Thirty-five patients were treated with vertebroplasty at one time and did not develop new fractures, whereas 20 patients returned with new fractures. Sixteen of 55 patients had been on steroid medication. The incidence of subsequent vertebral compression fractures after vertebroplasty in patients on long-term steroid therapy was 69{\%} (11/16), compared with 23{\%} (9/39) in those with primary osteoporosis (ie, those who were not on steroid therapy). There was a statistically significant association between use of steroids and new fractures (P < .01). No statistically significant difference was noted in patient age, sex, and medication for osteoporosis. CONCLUSION: Patients who are on long-term steroid medication have an elevated risk of developing new fractures after vertebroplasty.",
author = "Akio Hiwatashi and Westesson, {P. L.}",
year = "2007",
month = "6",
day = "1",
doi = "10.3174/ajnr.A0519",
language = "English",
volume = "28",
pages = "1055--1057",
journal = "American Journal of Neuroradiology",
issn = "0195-6108",
publisher = "American Society of Neuroradiology",
number = "6",

}

TY - JOUR

T1 - Patients with osteoporosis on steroid medication tend to sustain subsequent fractures

AU - Hiwatashi, Akio

AU - Westesson, P. L.

PY - 2007/6/1

Y1 - 2007/6/1

N2 - BACKGROUND AND PURPOSE: Repeat fractures after percutaneous vertebroplasty can be seen in patients with osteoporotic compression fractures. The purpose of this study was to identify characteristics of patients with new fractures after vertebroplasty. MATERIALS AND METHODS: Fifty-five consecutive patients were treated with vertebroplasty for painful osteoporotic compression fractures at our institution. The charts and radiographic studies of all patients were retrospectively reviewed. Special attention was paid to patient age and sex, imaging studies, long-term use of steroid medication, and treatment for osteoporosis. We used logistic regression analysis and the Fisher exact test for statistical evaluation. RESULTS: Thirty-five patients were treated with vertebroplasty at one time and did not develop new fractures, whereas 20 patients returned with new fractures. Sixteen of 55 patients had been on steroid medication. The incidence of subsequent vertebral compression fractures after vertebroplasty in patients on long-term steroid therapy was 69% (11/16), compared with 23% (9/39) in those with primary osteoporosis (ie, those who were not on steroid therapy). There was a statistically significant association between use of steroids and new fractures (P < .01). No statistically significant difference was noted in patient age, sex, and medication for osteoporosis. CONCLUSION: Patients who are on long-term steroid medication have an elevated risk of developing new fractures after vertebroplasty.

AB - BACKGROUND AND PURPOSE: Repeat fractures after percutaneous vertebroplasty can be seen in patients with osteoporotic compression fractures. The purpose of this study was to identify characteristics of patients with new fractures after vertebroplasty. MATERIALS AND METHODS: Fifty-five consecutive patients were treated with vertebroplasty for painful osteoporotic compression fractures at our institution. The charts and radiographic studies of all patients were retrospectively reviewed. Special attention was paid to patient age and sex, imaging studies, long-term use of steroid medication, and treatment for osteoporosis. We used logistic regression analysis and the Fisher exact test for statistical evaluation. RESULTS: Thirty-five patients were treated with vertebroplasty at one time and did not develop new fractures, whereas 20 patients returned with new fractures. Sixteen of 55 patients had been on steroid medication. The incidence of subsequent vertebral compression fractures after vertebroplasty in patients on long-term steroid therapy was 69% (11/16), compared with 23% (9/39) in those with primary osteoporosis (ie, those who were not on steroid therapy). There was a statistically significant association between use of steroids and new fractures (P < .01). No statistically significant difference was noted in patient age, sex, and medication for osteoporosis. CONCLUSION: Patients who are on long-term steroid medication have an elevated risk of developing new fractures after vertebroplasty.

UR - http://www.scopus.com/inward/record.url?scp=34250817389&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34250817389&partnerID=8YFLogxK

U2 - 10.3174/ajnr.A0519

DO - 10.3174/ajnr.A0519

M3 - Article

C2 - 17569956

AN - SCOPUS:34250817389

VL - 28

SP - 1055

EP - 1057

JO - American Journal of Neuroradiology

JF - American Journal of Neuroradiology

SN - 0195-6108

IS - 6

ER -